Activity-based costing of intensity- modulated proton versus photon therapy for oropharyngeal cancer

Nikhil G. Thaker, David Boyce-Fappiano, Matthew S. Ning, Dario Pasalic, Alexis Guzman, Grace Smith, Emma B. Holliday, James Incalcaterra, Adam S. Garden, Simona F. Shaitelman, G. Brandon Gunn, C. David Fuller, Pierre Blanchard, Thomas W. Feeley, Robert S. Kaplan, Steven J. Frank

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Purpose: In value-based health care delivery, radiation oncologists need to compare empiric costs of care delivery with advanced technologies, such as intensity-modulated proton therapy (IMPT) and intensity-modulated radiation therapy (IMRT). We used timedriven activity-based costing (TDABC) to compare the costs of delivering IMPT and IMRT in a case-matched pilot study of patients with newly diagnosed oropharyngeal (OPC) cancer. Materials and Methods: We used clinicopathologic factors to match 25 patients with OPC who received IMPT in 2011-12 with 25 patients with OPC treated with IMRT in 2000-09. Process maps were created for each multidisciplinary clinical activity (including chemotherapy and ancillary services) from initial consultation through 1 month of follow-up. Resource costs and times were determined for each activity. Each patient-specific activity was linked with a process map and TDABC over the full cycle of care. All calculated costs were normalized to the lowest-cost IMRT patient. Results: TDABC costs for IMRT were 1.00 to 3.33 times that of the lowest-cost IMRT patient (mean ± SD: 1.65 ± 0.56), while costs for IMPT were 1.88 to 4.32 times that of the lowest-cost IMRT patient (2.58 ± 0.39) (P < .05). Although single-fraction costs were 2.79 times higher for IMPT than for IMRT (owing to higher equipment costs), average full cycle cost of IMPT was 1.53 times higher than IMRT, suggesting that the initial cost increase is partly mitigated by reductions in costs for other, non-RT supportive health care services. Conclusions: In this matched sample, although IMPT was on average more costly than IMRT primarily owing to higher equipment costs, a subset of IMRT patients had similar costs to IMPT patients, owing to greater use of supportive care resources. Multidimensional patient outcomes and TDABC provide vital methodology for defining the value of radiation therapy modalities.

Original languageEnglish (US)
Pages (from-to)374-382
Number of pages9
JournalInternational Journal of Particle Therapy
Volume8
Issue number1
DOIs
StatePublished - Jun 1 2021

Keywords

  • IMPT
  • IMRT
  • Oropharyngeal carcinoma
  • Proton radiation therapy
  • TDABC
  • Timedriven activity-based costing

ASJC Scopus subject areas

  • Atomic and Molecular Physics, and Optics
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Activity-based costing of intensity- modulated proton versus photon therapy for oropharyngeal cancer'. Together they form a unique fingerprint.

Cite this